|
Bal Pharma Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
143.48 Cr.
|
P/BV
|
1.79
|
Book Value (Rs.)
|
50.32
|
|
52 Week High/Low (Rs.)
|
111/60
|
FV/ML
|
10/1
|
P/E(X)
|
22.70
|
|
Bookclosure
|
25/09/2025
|
EPS (Rs.)
|
3.97
|
Div Yield (%)
|
1.33
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 311.66 | 303.08 | 326.35 | 304.22 | 279.70 |
| Other Operating Revenues | 0.00 | 0.00 | 12.87 | 0.00 | 1.52 |
| Total Operating Revenues | 311.66 | 303.08 | 339.22 | 304.22 | 281.21 |
| | | | | | |
| Other Income | 1.93 | 2.20 | 2.85 | 0.94 | 5.15 |
| Total Revenue | 313.59 | 305.29 | 342.07 | 305.16 | 286.37 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 160.97 | 149.89 | 181.58 | 179.19 | 163.99 |
| Purchase Of Stock-In Trade | 9.23 | 15.06 | 11.24 | 11.45 | 8.43 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -12.23 | -7.05 | -1.06 | -17.87 | -4.89 |
| Employee Benefit Expenses | 66.46 | 62.40 | 60.38 | 55.30 | 47.25 |
| Finance Costs | 16.82 | 16.85 | 15.26 | 12.19 | 10.41 |
| Depreciation And Amortisation Expenses | 11.08 | 9.77 | 10.07 | 9.13 | 9.04 |
| Other Expenses | 55.33 | 53.23 | 55.56 | 51.03 | 42.96 |
| Total Expenses | 307.65 | 300.15 | 333.02 | 300.41 | 277.18 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 5.94 | 5.14 | 9.05 | 4.75 | 9.18 |
| | | | | | |
| Profit/Loss Before Tax | 5.94 | 5.14 | 9.05 | 4.75 | 9.18 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | -0.39 | 0.00 | 3.20 | 2.58 | 4.48 |
| Deferred Tax | 0.00 | -1.96 | 0.85 | 0.10 | -1.94 |
| Tax For Earlier Years | 0.00 | -0.14 | -2.45 | -0.55 | 0.94 |
| Total Tax Expenses | -0.39 | -2.10 | 1.60 | 2.13 | 3.48 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 6.32 | 7.24 | 7.45 | 2.62 | 5.70 |
| | | | | | |
| Profit/Loss From Continuing Operations | 6.32 | 7.24 | 7.45 | 2.62 | 5.70 |
| | | | | | |
| Profit/Loss For The Period | 6.32 | 7.24 | 7.45 | 2.62 | 5.70 |
| | | | | | |
| Minority Interest | 0.00 | -0.02 | -0.05 | -0.05 | -0.09 |
| Consolidated Profit/Loss After MI And Associates | 6.32 | 7.22 | 7.39 | 2.57 | 5.61 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 3.95 | 4.54 | 4.94 | 1.67 | 3.79 |
| Diluted EPS (Rs.) | 3.95 | 4.54 | 4.96 | 1.68 | 3.79 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 1.91 | 1.57 | 1.56 | 1.48 |
